July 22nd, 2020
A versatile vessel for next-gen therapeutics
Harvard’s ARMMs technology to be commercialized by Vesigen Therapeutics for targeted intracellular delivery of large-molecule drugs
News
Press Contact: Kirsten Mabry | (617) 495-4157
Featured Tags:
July 21st, 2020
Tough gel technology licensed to Amend Surgical for oral surgery applications
Medical device company will pursue development of strong, biocompatible adhesive that could replace sutures and dental membranes
July 10th, 2020
June 2020 patents
Innovations in the synthesis of tetracycline antibiotics, readying blood stem cells for transplantation, CRISPR systems, microfluidics, cancer vaccines, soft robotics, and more
June 17th, 2020
OTD welcomes 2020-2021 Blavatnik Fellows in Life Science Entrepreneurship
Five Fellows will work with innovators across Harvard community, advance commercialization of life-science technologies
June 9th, 2020
May 2020 patents
Innovations in soft robotics, evolving molecules in vitro, nucleic acid sequencing, hydrogels for tissue engineering, CRISPR enzymes and systems, analysis of animal behavior, and more